West Oak Capital LLC Cuts Stake in The Procter & Gamble Company (NYSE:PG)

West Oak Capital LLC decreased its position in The Procter & Gamble Company (NYSE:PG) by 3.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,047 shares of the company’s stock after selling 505 shares during the period. Procter & Gamble makes up approximately 1.1% of West Oak Capital LLC’s holdings, making the stock its 23rd biggest position. West Oak Capital LLC’s holdings in Procter & Gamble were worth $2,417,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of PG. Wyrmwood Management LLC bought a new stake in Procter & Gamble in the 4th quarter worth about $29,000. Itau Unibanco Holding S.A. bought a new stake in Procter & Gamble during the second quarter valued at approximately $50,000. CGC Financial Services LLC purchased a new stake in shares of Procter & Gamble in the 2nd quarter worth $55,000. VitalStone Financial LLC bought a new position in shares of Procter & Gamble in the second quarter worth about $60,000. Finally, RVW Wealth LLC bought a new stake in Procter & Gamble during the 3rd quarter worth approximately $77,000. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Down 0.1 %

Shares of Procter & Gamble stock traded down $0.17 on Thursday, reaching $162.44. The stock had a trading volume of 2,061,917 shares, compared to its average volume of 6,821,290. The Procter & Gamble Company has a 1 year low of $141.45 and a 1 year high of $163.14. The company has a 50 day moving average price of $158.17 and a 200 day moving average price of $152.09. The company has a quick ratio of 0.44, a current ratio of 0.64 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $382.22 billion, a P/E ratio of 27.18, a P/E/G ratio of 3.28 and a beta of 0.44.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Tuesday, January 23rd. The company reported $1.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.70 by $0.14. Procter & Gamble had a return on equity of 34.04% and a net margin of 17.60%. The business had revenue of $21.44 billion for the quarter, compared to the consensus estimate of $21.48 billion. During the same period in the prior year, the firm posted $1.59 earnings per share. The business’s quarterly revenue was up 3.2% on a year-over-year basis. As a group, equities research analysts forecast that The Procter & Gamble Company will post 6.45 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Friday, January 19th were issued a dividend of $0.9407 per share. The ex-dividend date was Thursday, January 18th. This represents a $3.76 annualized dividend and a dividend yield of 2.32%. Procter & Gamble’s dividend payout ratio (DPR) is presently 62.98%.

Wall Street Analyst Weigh In

PG has been the subject of a number of research reports. Royal Bank of Canada upped their target price on shares of Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 24th. Truist Financial upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and boosted their price target for the stock from $160.00 to $175.00 in a research report on Monday, March 11th. The Goldman Sachs Group initiated coverage on shares of Procter & Gamble in a research report on Friday, March 1st. They set a “neutral” rating and a $168.00 price objective for the company. Wells Fargo & Company boosted their target price on shares of Procter & Gamble from $162.00 to $170.00 and gave the stock an “overweight” rating in a report on Wednesday, January 24th. Finally, JPMorgan Chase & Co. reduced their price objective on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a research note on Thursday, January 18th. Seven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus price target of $168.41.

Insider Buying and Selling at Procter & Gamble

In other news, insider Marc S. Pritchard sold 101,704 shares of the company’s stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $153.57, for a total value of $15,618,683.28. Following the sale, the insider now owns 163,428 shares in the company, valued at $25,097,637.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Marc S. Pritchard sold 101,704 shares of the firm’s stock in a transaction on Wednesday, January 24th. The shares were sold at an average price of $153.57, for a total transaction of $15,618,683.28. Following the sale, the insider now owns 163,428 shares in the company, valued at $25,097,637.96. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Ma. Fatima Francisco sold 74,443 shares of the company’s stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $153.30, for a total transaction of $11,412,111.90. Following the completion of the transaction, the chief executive officer now owns 973 shares of the company’s stock, valued at approximately $149,160.90. The disclosure for this sale can be found here. In the last quarter, insiders sold 279,063 shares of company stock worth $43,187,745. Insiders own 0.17% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.